Gore, CA
Anand Gore, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090073941 | MESH NETWORK CONNECTING 3G WIRELESS ROUTERS - A communication routing arrangement includes two or more wireless routers coupled to a communication network, and a user device adapted to couple with the communication network through a communication path including at least one of the two or more wireless routers. The communication path between the user device and the communication network is selected based on available resources of the two or more wireless routers. | 03-19-2009 |
20100290442 | SYSTEMS AND METHODS FOR AUTOMATIC CONNECTION WITH A WIRELESS NETWORK - A Intelligent Mobile HotSpot (IMHS) comprises a wide area network radio interface configured to enable communications between a wide area network and the IMHS; a local area network radio interface configured to enable communications between the IMHS and a computing device; a power input configured to cause the IMHS to be powered on; memory configured to store instructions; and a processor coupled with memory, the instructions configured to cause the processor to perform the following in response to an activation of the power input: automatically establish a data connection with a base station associated with the wide area network over the wide area network, automatically establish a data connection with computing device over the local area network, and be in a ready state to route data packets from the computing device to the base station via the local area network data connection and the wide area network connection. | 11-18-2010 |
20100290444 | SYSTEMS AND METHODS FOR AUTOMATIC CONNECTION WITH A WIRELESS NETWORK - A Intelligent Mobile HotSpot (IMHS) comprises a wide area network radio interface configured to enable communications between a wide area network and the IMHS; a local area network radio interface configured to enable communications between the IMHS and a computing device; a power input configured to cause the IMHS to be powered on; memory configured to store instructions; and a processor coupled with memory, the instructions configured to cause the processor to perform the following in response to an activation of the power input: automatically establish a data connection with a base station associated with the wide area network over the wide area network, automatically establish a data connection with computing device over the local area network, and be in a ready state to route data packets from the computing device to the base station via the local area network data connection and the wide area network connection. | 11-18-2010 |
20110305199 | WIRELESS ROUTER SYSTEMS AND METHODS - A communication routing arrangement includes two or more wireless routers coupled to a communication network, and a user device adapted to couple with the communication network through a communication path including at least one of the two or more wireless routers. The communication path between the user device and the communication network is selected based on available resources of the two or more wireless routers. | 12-15-2011 |
20120287899 | MESH NETWORK CONNECTING 3G WIRELESS ROUTERS - A communication routing arrangement includes two or more wireless routers coupled to a communication network, and a user device adapted to couple with the communication network through a communication path including at least one of the two or more wireless routers. The communication path between the user device and the communication network is selected based on available resources of the two or more wireless routers. | 11-15-2012 |
20120294260 | MESH NETWORK CONNECTING 3G WIRELESS ROUTERS - A communication routing arrangement includes two or more wireless routers coupled to a communication network, and a user device adapted to couple with the communication network through a communication path including at least one of the two or more wireless routers. The communication path between the user device and the communication network is selected based on available resources of the two or more wireless routers. | 11-22-2012 |
Anuradha Gore, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20110294744 | CYCLOSPORIN EMULSIONS - Disclosed herein is a composition comprising cyclosporin A at a concentration between about 0.001% (w/v) and about 1.0% (w/v), a plant oil at a concentration between about 0.01% (w/v) and about 10% (w/v), and macrogol 15 hydroxystearate at a concentration between about 0.01% (w/v) and about 10% (w/v). | 12-01-2011 |
20130122059 | SUSPENSIONS OF CYCLOSPORIN A FORM 2 - Disclosed herein are methods of formulating cyclosporin A Form 2. | 05-16-2013 |
Anuradha V. Gore, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20110105581 | OPHTHALMIC FORMULATIONS CONTAINING SUBSTITUTED GAMMA LACTAMS AND METHODS FOR USE THEREOF - The invention provides ophthalmic formulations containing well-defined substituted gamma lactams. The formulations described herein are useful in treating a variety of ocular diseases related to ocular hypertension, such as for example, glaucoma. | 05-05-2011 |
20110112198 | COMPOSITIONS FOR ENHANCING HAIR GROWTH - Methods and compositions for stimulating the growth of hair are disclosed wherein emulsions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I | 05-12-2011 |
20120190661 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION - The disclosure provides compositions for treating an ocular condition. The composition comprises a physiologically effective amount of an androgen, wherein the composition is suitable for topical administration to an eye. The disclosure further provides methods for treating an ocular condition with the disclosed compositions. | 07-26-2012 |
20120201910 | Artificial Tears and Therapeutic Uses - The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc. | 08-09-2012 |
20130005665 | MACROGOL 15 HYDROXYSTEARATE FORMULATIONS - Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder. | 01-03-2013 |
20130011354 | Compositions For Enhancing Hair Growth - Methods and compositions for stimulating the growth of hair are disclosed wherein emulsions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent a single or double bond which can be in the cis or trans configuration, A, B, Z, X, R | 01-10-2013 |
20130023482 | CRYSTALLINE FORM OF CYCLOSPORINE A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF - The present invention relates generally to crystalline forms of cyclosporine A and particularly to a newly identified form of cyclosporine A. The invention further relates to methods for its preparation and to methods for treating certain ocular disorders. | 01-24-2013 |
20130023536 | FIXED DOSE COMBINATION OF BIMATOPROST AND BRIMONIDINE - The present invention is directed to compositions comprising combinations of brimonidine and bimatoprost useful for lowering intraocular pressure in a patient and for the treatment of glaucoma | 01-24-2013 |
20130029919 | TWO PART FORMULATION SYSTEM FOR OPTHALMIC DELIVERY - Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent. | 01-31-2013 |
20130157963 | OPHTHALMIC COMPOSITIONS COMPRISING POLYVINYL CAPRALACTAM-POLYVINYL ACETATE-POLYETHYLENE GLYCOL GRAFT COPOLYMERS - Compositions and methods related to ophthalmic use of polyvinyl capralactam-polyvinyl acetate-polyethylene glycol graft copolymers and therapeutic uses are described herein. | 06-20-2013 |
20140315827 | CRYSTALLINE FORM OF CYCLOSPORINE A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF - The present invention relates generally to crystalline forms of cyclosporine A and particularly to a newly identified form of cyclosporine A. The invention further relates to methods for its preparation and to methods for treating certain ocular disorders. | 10-23-2014 |
20140315872 | NON-IRRITATING TESTOSTERONE EMULSIONS - Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease. | 10-23-2014 |
20140322335 | SUSPENSIONS OF CYCLOSPORIN A FORM 2 - Disclosed herein are methods of formulating cyclosporin A Form 2. | 10-30-2014 |
Anuradha V. Gore, Aliso Viejo, CA US
Patent application number | Description | Published |
---|---|---|
20130295206 | ARTIFICIAL TEARS AND THERAPEUTIC USES - The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e. g. olive oil, sesame oil, corn oil etc. | 11-07-2013 |
20140128329 | OPHTHALMIC COMPOSITIONS COMPRISING POLYVINYL CAPROLACTAM-POLYVINYL ACETATE-POLYETHYLENE GLYCOL GRAFT COPOLYMERS - Compositions and methods related to ophthalmic use of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers and therapeutic uses are described herein. | 05-08-2014 |
20140141106 | ARTIFICIAL TEARS AND THERAPEUTIC USES - The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc. | 05-22-2014 |
20140249153 | FIXED DOSE COMBINATION OF BIMATOPROST AND BRIMONIDINE - The present invention is directed to compositions comprising combinations of brimonidine and bimatoprost useful for lowering intraocular pressure in a patient and for the treatment of glaucoma. | 09-04-2014 |
20140287988 | MACROGOL 15 HYDROXYSTEARATE FORMULATIONS - Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder. | 09-25-2014 |
20140364379 | TWO PART FORMULATION SYSTEM FOR OPHTHALMIC DELIVERY - Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent. | 12-11-2014 |
Anuradha V. Gore, Aliso Viego, CA US
Patent application number | Description | Published |
---|---|---|
20150045309 | CYCLOSPORIN EMULSIONS - Disclosed herein is a composition comprising cyclosporin A at a concentration between about 0.001% (w/v) and about 1.0% (w/v), a plant oil at a concentration between about 0.01% (w/v) and about 10% (w/v), and macrogol 15 hydroxystearate at a concentration between about 0.01% (w/v) and about 10% (w/v). | 02-12-2015 |
Ashok Gore, Tustin, CA US
Patent application number | Description | Published |
---|---|---|
20110251143 | STABLE ELSAMITRUCIN SALT FORMULATIONS - Formulations containing stable forms of elsamitrucin salts are provided. These formulations are useful for treating neoplastic diseases and conditions. | 10-13-2011 |
Ashok Yeshwant Gore, Tustin, CA US
Patent application number | Description | Published |
---|---|---|
20110280956 | LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE - The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia. | 11-17-2011 |
20140161885 | LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE - The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia. | 06-12-2014 |
Athurva Gore, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20140357497 | DESIGNING PADLOCK PROBES FOR TARGETED GENOMIC SEQUENCING - Methods, systems, and computer programs for designing probes or primers for nucleic acid sequencing, generating libraries of nucleic acid sequences, and mapping genomic sequences are provided herein, | 12-04-2014 |
Brian Gore, Naperville, CA US
Patent application number | Description | Published |
---|---|---|
20080287967 | Device and Methods for Suturing Tissue - Systems for suturing a tissue layer having two sides with a suture be releasably retaining at least a portion of the suture in a stationary position on one side of the tissue layer. The portion of the suture is retrieved through the tissue layer from the opposite side whereby the suture is drawn from one side to the opposite side. Systems for suturing the wall of a tubular graft having two sides is also provided using a suture by releasably retaining at least a portion of the suture on one side of the wall. the portion of the length of suture is retrieved through the wall of the graft to the opposite side of the wall. | 11-20-2008 |
Dhananjay Gore, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100056123 | INTER-SECTOR CONTROL CHANNEL TRANSMISSION - Provided is a more efficient manner of transmitting a control message to reach into a neighboring sector (e.g., inter-sector) of a wireless network environment. The control message can be utilized for purposes such as handoff, indicating an amount of interference, inter-sector power control for managing inter-sector interference, sector loading, or other control messages. The control message can be placed on a set of resources utilizing planned reuse and/or statistical reuse. Statistical reuse includes selecting a subcarrier set for carrying the control message. According to some aspects, the control message can be sent over a backhaul channel. | 03-04-2010 |
20100254354 | Softer and Soft Handoff in an Orthogonal Frequency Division Wireless Communication System - Transmission patterns for pilot symbols transmitted from a mobile station or base station are provided. The patterns may be selected according to a location of the mobile station with respect to one or more antennas are provided. In some aspects, the pattern may be selected based upon the distance between the mobile station and the one or more antennas. In other aspect, the pattern may be based upon whether the mobile station is in handoff. | 10-07-2010 |
20100329310 | LOW COMPLEXITY BEAMFORMING FOR MULTIPLE ANTENNA SYSTEMS - Methods and apparatuses are disclosed that utilize the discrete Fourier transform of time domain responses to generate beamforming weights for wireless communication. In addition, in some embodiments frequency subcarriers constituting less than all of the frequency subcarriers allocated for communication to a user may utilized for generating the beamforming weights. | 12-30-2010 |
Dhananjay Ashok Gore, Dan Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100285739 | MULTI-METRIC GAIN CONTROL FOR WIRELESS REPEATER - A method for controlling gain in a wireless repeater includes using two or more gain control metrics indicative of stability of the repeater, at least two of the gain control metrics having different integration lengths, where the integration length is the sum of the coherent integration time and the non coherent integration time, and controlling a variable gain value of the repeater based on one or more of the selected gain control metric(s) where the gain control metric(s) to use is selected based on the stability of the repeater. | 11-11-2010 |
Medini Gore, Los Altos, CA US
Patent application number | Description | Published |
---|---|---|
20140308287 | SUR-BINDING PROTEINS - Embodiments concern constructs comprising surrogate light chain sequences. In particular, embodiments concern constructs that can bind to ErbB3 and aspects relating to such constructs. | 10-16-2014 |
20150045540 | MULTISPECIFIC STACKED VARIABLE DOMAIN BINDING PROTEINS - The present invention concerns multi-specific stacked variable domain binding proteins. | 02-12-2015 |
Mukta Gore, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20140187331 | LATENCY REDUCTION BY SUB-FRAME ENCODING AND TRANSMISSION - A cloud gaming system includes a cloud gaming server that provides rendering for a video frame employed in cloud gaming. The cloud gaming system also includes a video frame latency reduction pipeline coupled to the cloud gaming server, having a slice generator that provides a set of separately-rendered video frame slices required for a video frame, a slice encoder that encodes each of the set of separately-rendered video frame slices into corresponding separately-encoded video frame slices of the video frame and a slice packetizer that packages each separately-encoded video frame slice into slice transmission packets. The cloud gaming system further includes a cloud network that transmits the slice transmission packets and a cloud gaming client that processes the slice transmission packets to construct the video frame. A video frame latency reduction method is also provided. | 07-03-2014 |
Ravindra G. Gore, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20120226535 | METHODS AND SYSTEMS FOR PAYING WITH LOYALTY CURRENCY DURING ONLINE PAYMENT - Methods and systems for paying with loyalty currency at a merchant website by a user using a browser app are provided. The user is presented with the loyalty currency balance information based on the loyalty currency units available in the loyalty currency account. Thereafter, the user is presented with an option to pay for the purchase transaction using the loyalty currency. The user may select the option of paying for the purchase transaction using the loyalty currency, thereby redeeming the loyalty points. | 09-06-2012 |
20120246073 | SYSTEMS AND METHODS FOR TRANSFERRING TRANSACTION INSTRUCTIONS FROM A REMOTE REPOSITORY TO A MERCHANT WEBSITE USING A TRANSACTION AGENT - Systems and methods for transferring transaction instructions from a remote repository to a participating merchant website using a transaction agent are provided. A user is provided an option of checking out of a merchant website by using a transaction assistant option that requires the user to be authenticated with an activity server. Subsequent to successful authentication, the pre-stored transactional instructions such as user payment method details, the shipping information, and the like are accessed from a payment store and transferred to the transaction terminal at the merchant website for completion of the transaction. | 09-27-2012 |
20140058821 | METHODS AND SYSTEMS FOR PAYING WITH LOYALTY CURRENCY DURING ONLINE PAYMENT - Methods and systems for paying with loyalty currency at a merchant website by a user using a browser app are provided. The user is presented with the loyalty currency balance information based on the loyalty currency units available in the loyalty currency account. Thereafter, the user is presented with an option to pay for the purchase transaction using the loyalty currency. The user may select the option of paying for the purchase transaction using the loyalty currency, thereby redeeming the loyalty points. | 02-27-2014 |
Richard Gore, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20090006616 | END-TO-END PERFORMANCE TOOL AND METHOD FOR MONITORING ELECTRONIC-COMMERCE TRANSACTIONS - A method and apparatus for monitoring electronic commerce transactions. A network delay agent, coupled to the access point for the electronic commerce provider's system is operable to send and receive communications to a designated customer's site for measuring network transport latency. Application test latency is also determined. An application monitor agent that is coupled to the electronic commerce provider's access point sends application tests that correspond to tasks performed during a typical electronic commerce transaction, to the electronic commerce provider's system. The time required for the electronic commerce provider's system to perform the indicated tasks and return a response to the application monitor agent is recorded as application test latency. Network transport latency and application test latency are displayed to indicate the delays that are experienced by a user in executing an electronic commerce order. | 01-01-2009 |
Vijay K. Gore, Thousand Oaks, CA US
Patent application number | Description | Published |
---|---|---|
20090143575 | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS - Therapeutic benzimidazoles and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotizing agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders. | 06-04-2009 |
20100261728 | TRP-M8 RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS - Tetrahydroisoquinoline compounds of formula (I), and compositions containing them, for the treatment of acute, inflammatory and neurophatic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neurophatic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders. | 10-14-2010 |
Vijay Keshav Gore, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20130157996 | TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS - Compounds of Formula I are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: | 06-20-2013 |
20130158034 | TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS - Compounds of Formula I are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: | 06-20-2013 |
Vijay Keshav Gore, Thousand Oaks, CA US
Patent application number | Description | Published |
---|---|---|
20090197879 | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS - Compounds having the general structure | 08-06-2009 |
20100087429 | SPIRO-TRICYCLIC RING COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE - The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I | 04-08-2010 |
20110118234 | Urea Compounds as Gamma Secretase Modulators - The present invention provides compounds Formula (I) that are gamma secretase modulators and are therefore useful for the treatment of diseases treatable by modulation of gamma secretase such as Alzheimer's disease. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds. | 05-19-2011 |
20110251190 | SPIRO-TETRACYCLIC RING COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE - The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and other related conditions. In one embodiment, the compounds have a general Formula I | 10-13-2011 |
Vijay Keshav Gore, Aliso Viejo, CA US
Patent application number | Description | Published |
---|---|---|
20140045855 | CHROMAN DERIVATIVES AS TRPM8 INHIBITORS - Chroman compounds and derivatives of Formula I are useful inhibitors of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: | 02-13-2014 |
20140171406 | TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS - Compounds of Formula I are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: | 06-19-2014 |
20140171639 | TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS - Compounds of Formula I are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: | 06-19-2014 |
20140235642 | TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS - Compounds of Formula I are useful as antagonists of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: | 08-21-2014 |
20150031668 | CHROMAN DERIVATIVES AS TRPM8 INHIBITORS - Chroman compounds and derivatives of Formula I are useful inhibitors of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: | 01-29-2015 |